rs2234968

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001008212.2(OPTN):​c.102G>A​(p.Thr34Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.251 in 1,613,578 control chromosomes in the GnomAD database, including 53,239 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3653 hom., cov: 30)
Exomes 𝑓: 0.26 ( 49586 hom. )

Consequence

OPTN
NM_001008212.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -3.19

Publications

57 publications found
Variant links:
Genes affected
OPTN (HGNC:17142): (optineurin) This gene encodes the coiled-coil containing protein optineurin. Optineurin may play a role in normal-tension glaucoma and adult-onset primary open angle glaucoma. Optineurin interacts with adenovirus E3-14.7K protein and may utilize tumor necrosis factor-alpha or Fas-ligand pathways to mediate apoptosis, inflammation or vasoconstriction. Optineurin may also function in cellular morphogenesis and membrane trafficking, vesicle trafficking, and transcription activation through its interactions with the RAB8, huntingtin, and transcription factor IIIA proteins. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
OPTN Gene-Disease associations (from GenCC):
  • glaucoma, normal tension, susceptibility to
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • amyotrophic lateral sclerosis type 12
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Genomics England PanelApp
  • glaucoma 1, open angle, E
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 10-13109224-G-A is Benign according to our data. Variant chr10-13109224-G-A is described in ClinVar as Benign. ClinVar VariationId is 96022.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.19 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.266 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPTNNM_001008212.2 linkc.102G>A p.Thr34Thr synonymous_variant Exon 3 of 15 ENST00000378747.8 NP_001008213.1
OPTNNM_001008211.1 linkc.102G>A p.Thr34Thr synonymous_variant Exon 4 of 16 NP_001008212.1
OPTNNM_001008213.1 linkc.102G>A p.Thr34Thr synonymous_variant Exon 4 of 16 NP_001008214.1
OPTNNM_021980.4 linkc.102G>A p.Thr34Thr synonymous_variant Exon 2 of 14 NP_068815.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPTNENST00000378747.8 linkc.102G>A p.Thr34Thr synonymous_variant Exon 3 of 15 1 NM_001008212.2 ENSP00000368021.3

Frequencies

GnomAD3 genomes
AF:
0.199
AC:
30209
AN:
151882
Hom.:
3651
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0535
Gnomad AMI
AF:
0.105
Gnomad AMR
AF:
0.255
Gnomad ASJ
AF:
0.320
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.235
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.312
Gnomad NFE
AF:
0.269
Gnomad OTH
AF:
0.235
GnomAD2 exomes
AF:
0.242
AC:
60876
AN:
251260
AF XY:
0.244
show subpopulations
Gnomad AFR exome
AF:
0.0479
Gnomad AMR exome
AF:
0.283
Gnomad ASJ exome
AF:
0.329
Gnomad EAS exome
AF:
0.202
Gnomad FIN exome
AF:
0.179
Gnomad NFE exome
AF:
0.273
Gnomad OTH exome
AF:
0.260
GnomAD4 exome
AF:
0.256
AC:
374781
AN:
1461578
Hom.:
49586
Cov.:
34
AF XY:
0.256
AC XY:
186429
AN XY:
727108
show subpopulations
African (AFR)
AF:
0.0443
AC:
1482
AN:
33478
American (AMR)
AF:
0.278
AC:
12444
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.329
AC:
8599
AN:
26136
East Asian (EAS)
AF:
0.187
AC:
7433
AN:
39700
South Asian (SAS)
AF:
0.221
AC:
19104
AN:
86254
European-Finnish (FIN)
AF:
0.187
AC:
9963
AN:
53370
Middle Eastern (MID)
AF:
0.296
AC:
1710
AN:
5768
European-Non Finnish (NFE)
AF:
0.269
AC:
298939
AN:
1111774
Other (OTH)
AF:
0.250
AC:
15107
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
15432
30865
46297
61730
77162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9882
19764
29646
39528
49410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.199
AC:
30209
AN:
152000
Hom.:
3653
Cov.:
30
AF XY:
0.197
AC XY:
14651
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.0533
AC:
2214
AN:
41528
American (AMR)
AF:
0.255
AC:
3896
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.320
AC:
1112
AN:
3472
East Asian (EAS)
AF:
0.187
AC:
964
AN:
5146
South Asian (SAS)
AF:
0.234
AC:
1122
AN:
4788
European-Finnish (FIN)
AF:
0.182
AC:
1922
AN:
10564
Middle Eastern (MID)
AF:
0.312
AC:
91
AN:
292
European-Non Finnish (NFE)
AF:
0.269
AC:
18290
AN:
67920
Other (OTH)
AF:
0.237
AC:
502
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1147
2293
3440
4586
5733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.246
Hom.:
16413
Bravo
AF:
0.199
Asia WGS
AF:
0.210
AC:
731
AN:
3478
EpiCase
AF:
0.284
EpiControl
AF:
0.283

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 21, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 10, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19172505, 17122126, 28993189, 31198474, 17361544) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Amyotrophic lateral sclerosis type 12 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Primary open angle glaucoma;C1842026:Glaucoma 1, open angle, E;C3150692:Amyotrophic lateral sclerosis type 12 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary open angle glaucoma Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.70
DANN
Benign
0.78
PhyloP100
-3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234968; hg19: chr10-13151224; COSMIC: COSV53809457; COSMIC: COSV53809457; API